DJIA 17,719.00 33.27 0.19%
NASDAQ 4,701.87 26.16 0.56%
S&P 500 2,052.75 4.03 0.20%
market minute promo

6.57 0.43 (7.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARIA $6.57 7.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.12
Previous Close $6.14
Daily Range $6.09 - $6.60
52-Week Range $2.53 - $9.83
Market Cap $1.2B
P/E Ratio -4.95
Dividend (Yield) $0.00 (0.0%)
Volume 8,486,409
Average Daily Volume 5,960,809
Current FY EPS -$1.09





Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website:

News & Commentary Rss Feed

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

Ariad Pharmaceuticals stock is among today's top gainers after the Food and Drug Administration divvies a prized designation one of Ariad's pipeline products.

'Mad Money' Lightning Round: A Group to Avoid

Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health Stocks Generally Higher Pre-Bell

ARIAD Pharmaceuticals (ARIA) Q3 2014 Results - Earnings Call Webcast

Earnings Scheduled For November 5, 2014

Will ARIAD (ARIA) Miss This Earnings Season? - Analyst Blog

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

See More ARIA News...

ARIA's Top Competitors

ARIA $6.57 (7.00%)
Current stock: ARIA
AMGN $162.68 (0.02%)
Current stock: AMGN
GILD $100.59 (-1.71%)
Current stock: GILD
BIIB $299.10 (-1.49%)
Current stock: BIIB